Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - NET CHANGE IN CASH
Net Change in Cash AVTX - Avalo Therapeutics, Inc.
-5.77 M
LAST VALUE
-7.77%
2 YEAR CAGR
-11.31%
5 YEAR CAGR
0.55%
10 YEAR CAGR